Seoul, Korea – December 23, 2025 – (SeaPRwire) – The Third Market Co., Ltd. has opened Korea’s first Experiential Refurbished Electronics Showroom, a space where customers can directly test, compare, and verify refurbished electronics with full transparency. The showroom was created to solve long-standing consumer concerns around inconsistent quality and unclear product history in the refurb market.
The Third Market manages the entire process in-house, including inspection, grading, labeling, and warranty issuance. Visitors can observe real-time inspection, review visualized product reports, and experience devices firsthand—shifting refurbished products from “low-cost alternatives” to “value-verified choices.”
The showroom integrates an inspection center, exhibition zone, and logistics area, enabling seamless processing from intake to purchase. With its internal branding and design team, Third Market provides standardized labels, branded packaging, and expert consultations to enhance consumer trust.
A dedicated Small Business Pop-Up Zone also supports local merchants by offering a new retail channel for overstock and returned goods, contributing to a healthier refurb ecosystem.
“Our goal is to establish a new standard of trust in refurbished electronics,” said CEO Sang-ho Yoo. “Customers should be able to see exactly how products are evaluated and feel confident in their value.”
The Third Market plans to expand additional hubs, enhance automated inspection technology, and strengthen global partnerships as it shapes the future of the refurbished electronics market.
Media contact
Brand: The Third Market
Contact: Sang-ho Yoo
Phone: +821041143582
Email: biz@ttm.imWebsite: https://shop.ttm.im
Singapore – December 22, 2025 – (SeaPRwire) – Asia Pricing Professionals (APP), the leading pricing and commercial excellence community in Asia-Pacific, today announced a major expansion of its professional development, certification, and community platform for 2026. The expanded portfolio positions APP as the region’s most comprehensive ecosystem for pricing, value management, and revenue excellence.
Central to the 2026 expansion is a strategic partnership with the Professional Pricing Society (PPS), connecting global best practices with regional execution to support individuals, teams, and organizations as pricing evolves into a strategic, AI-enabled business capability.
Comprehensive Pricing Training & Global Certifications
From 2026, APP members will gain access to 100+ on-demand pricing courses through its collaboration with PPS, covering the full pricing and monetization lifecycle — from foundational principles to advanced real-world application.
The curriculum spans:
Pricing strategy and value creation
Pricing analytics and data-driven decision-making
Execution, governance, and price realization
Negotiation and deal pricing
SaaS and XaaS monetization models
AI-enabled pricing and advanced analytics
Organizational design and change management
In addition, APP will offer globally recognized certifications, including the Certified Pricing Professional (CPP®) designation — the only worldwide credential synthesizing the art and science of pricing — and a new AI Pricing Certification, designed to help professionals apply artificial intelligence responsibly and effectively in pricing, forecasting, and commercial decision-making.
Two Flagship APP Conferences in Singapore (2026)
As part of its expanded offering, APP will host two one-day flagship conferences in Singapore in 2026, bringing together senior pricing, commercial, and revenue leaders from across Asia-Pacific.
APP Conference 1
5 March 2026 | Singapore
Theme: Smart Value: AI and the Future of Pricing & Revenue Growth
The conference will explore how AI, analytics, and advanced pricing capabilities are transforming value creation, pricing decisions, and sustainable revenue growth.
Key topics include AI-driven pricing, predictive analytics, price corridors, deal pricing, execution excellence, and ethics and governance in AI-enabled pricing.
APP Conference 2
15 October 2026 | Singapore
Theme: Total Revenue Excellence: Integrating Pricing, Profitability & Commercial Performance
This event will focus on breaking organizational silos between Pricing, Sales, Finance, Revenue Management, and Commercial Operations to drive end-to-end revenue and profit performance.
Key topics include deal desk design, discount discipline, KPI alignment, commercial operating models, and scaling revenue excellence across regions.
Face-to-Face Training & Regional Networking
Immediately following each conference, APP will deliver in-person, instructor-led training programs in Singapore on 6 March and 16 October 2026. These hands-on sessions focus on applied execution and advanced case work, and both count toward CPP® certification credits.
In the second half of 2026, APP will also launch its “Five Big Cities” Networking Tour, with events planned in:
Bangkok
Jakarta
Manila
Shanghai
Singapore
Each event will feature curated networking, practitioner roundtables, and thought leadership discussions, strengthening APP’s role as a regional connector between local markets and global best practices.
An Integrated Pricing Ecosystem for Asia-Pacific
Together, APP’s training, certifications, conferences, live programs, and regional networking form a single integrated ecosystem designed to:
Build pricing and commercial capability at scale
Bridge theory with real-world execution
Support career progression and organizational maturity
Advance ethical, data-driven, and AI-enabled pricing across Asia-Pacific
About Asia Pricing Professionals (APP)
Founded in 2010, Asia Pricing Professionals is a not-for-profit community dedicated to advancing pricing, value management, and commercial excellence across Asia-Pacific. APP connects practitioners, leaders, and organizations through education, certification, events, and peer collaboration.
Social Links
LinkedIn: https://www.linkedin.com/groups/3813123/
Instagram: https://www.instagram.com/asiapricingprofessionals
Media contact
Brand: Asia Pricing Professionals
Contact: Media team
Email: deepaksood@asiapricingprofessionals.org
Website: https://asiapricingprofessionals.org
SHENZHEN, Dec 15, 2025 – (ACN Newswire via SeaPRwire.com) – China Medical System Holdings Limited (“CMS”, or the “Group”) is pleased to announce that its subsidiary, Dermavon Holdings Limited (“Dermavon”, an innovative pharmaceutical company specialized in skin health which is applying for an independent listing on the Main Board of The Stock Exchange of Hong Kong Limited, please refer to the announcement of the Company dated 22 April 2025 for details), has obtained the relevant licensing rights to the innovative oral JAK1 inhibitor povorcitinib (proposed English generic name: Povorcitinib Phosphate Tablets) (“povorcitinib” or the “Product”), which has been included in the list of Breakthrough Therapeutic Drugs by the Center for Drug Evaluation of the National Medical Products Administration of the People’s Republic of China (“NMPA”), with a proposed indication for adult patients with non-segmental vitiligo. This certification has the potential to accelerate the development and review process of the Product.
Povorcitinib is a selective oral small-molecule JAK1 inhibitor, with compound and use patents in certain countries/regions in the Territory. Currently, povorcitinib is in Phase 3 clinical trials for non-segmental vitiligo, moderate to severe hidradenitis suppurativa (HS) and prurigo nodularis in several countries outside China. A Phase 2 clinical trial for the treatment of asthma is also ongoing.
In March 2023, Incyte announced that povorcitinib met the primary endpoint in a global multi-center Phase 2b clinical trial for non-segmental vitiligo. Results showed that after 24 weeks of treatment, compared with vehicle, total body repigmentation of patients treated with povorcitinib once daily was significantly improved. Furthermore, according to the extended Phase 2b trial, longer-term use of povorcitinib demonstrated further improvement in total body and facial repigmentation with a favorable tolerability profile[1].
In August 2025, Dermavon received the drug clinical trial approval notice issued by NMPA to conduct clinical trials of povorcitinib for the treatment of non-segmental vitiligo and other indications. Dermavon has initiated the clinical development of the Product in China and may consider further initiating clinical development of povorcitinib in China for the treatment of skin-related diseases such as HS and prurigo nodularis in the future.
Vitiligo is a chronic autoimmune disease characterized by depigmentation of the skin, which results from the loss of pigment-producing cells known as melanocytes. It is estimated that there are approximately 10.3 million vitiligo patients in China and non-segmental vitiligo patients account for approximately 8.2 million[2]. Currently, therapeutic options for vitiligo are limited, and the condition is difficult to treat, especially for patients with moderate to severe extensive vitiligo. If approved in China, povorcitinib could provide a differentiated treatment option for patients with non-segmental vitiligo.
The Product’s inclusion in the list of Breakthrough Therapeutic Drugs is expected to accelerate its development and review process in mainland China. If approved for marketing in China, the Product has the potential to synergize with Dermavon’s commercialized innovative drug ILUMETRI (tildrakizumab injection), commercialized exclusive drug Hirudoid (mucopolysaccharide polysulfate cream) and the innovative drug currently under New Drug Application (NDA) review ruxolitinib phosphate cream, helping the product to quickly realize its clinical and commercial value and benefit more patients with skin diseases. Furthermore, if approved, the Product, together with topical ruxolitinib phosphate cream, will provide vitiligo patients with differentiated and comprehensive treatment options.
The Group, through a subsidiary of Dermavon entered into a Collaboration and License Agreement (the “License Agreement”) for povorcitinib on 31 March 2024 with Incyte, obtaining an exclusive license to research, develop, register and commercialize the Product in Mainland China, Hong Kong Special Administrative Region, Macao Special Administrative Region, Taiwan Region and eleven Southeast Asian countries (the “Territory”) and a non-exclusive license to manufacture the Product in the Territory. The subsidiary of Dermavon has sublicensed the relevant rights of povorcitinib in the Territory other than Mainland China to the Group (excluding Dermavon and its subsidiaries).
About CMS
CMS is a platform company linking pharmaceutical innovation and commercialization with strong product lifecycle management capability, dedicated to providing competitive products and services to meet unmet medical needs.
CMS focuses on the global first-in-class (FIC) and best-in-class (BIC) innovative products, and efficiently promotes the clinical research, development and commercialization of innovative products, enabling the continuous transformation of scientific research into clinical practices to benefit patients.
CMS deeply engages in several specialty therapeutic fields, and has developed proven commercialization capabilities, extensive networks and expert resources, resulting in leading academic and market positions for its major marketed products. CMS continues to promote the in-depth development in its advantageous specialty fields, strengthening the competitiveness of the cardio-cerebrovascular/ gastroenterology/ ophthalmology/ skin health businesses, bringing economies of scale in specialty fields. Among them, the skin health business (Dermavon) has become a leading enterprise in its field, and is proposed to be listed independently on the SEHK. Meanwhile, CMS continuously promotes the operation and development of its integrated R&D, manufacturing and commercialization chain in Southeast Asia and the Middle East, capturing growth opportunities in emerging markets to support the high-quality and sustainable development of the Group.
Reference:
1. Results from a global multi-center Phase 2b clinical trial of the product for non-segmental vitiligo indication can be found on the Incyte official website: https://investor.incyte.com/news-releases/news-release-details/incyte-announces-data-phase-2b-study-evaluating-povorcitinib
2. Datas are from the China Insights Consultancy (CIC) report
CMS Disclaimer and Forward-Looking Statements
This press release is not intended to promote any products to you and is not for advertising purposes. This press release does not recommend any drugs, medical devices and/or indications. If you want to know more about the diagnosis and treatment of specific diseases, please follow the opinions or guidance of your doctor or other medical and health professionals. Any treatment-related decisions made by healthcare professionals should be based on the patient’s specific circumstances and in accordance with the drug package insert.
This press release which has been prepared by CMS does not constitute any offer or invitation to purchase or subscribe for any securities, and shall not form the basis for or be relied on in connection with any contract or binding commitment whatsoever. This press release has been prepared by CMS based on information and data which it considers reliable, but CMS makes no representation or warranty, express or implied, whatsoever, and no reliance shall be placed on, the truth, accuracy, completeness, fairness and reasonableness of the contents of this press release. Certain matters discussed in this press release may contain statements regarding the Group’s market opportunity and business prospects that are individually and collectively forward-looking statements. Such forward-looking statements are not guarantees of future performance and are subject to known and unknown risks, uncertainties and assumptions that are difficult to predict. Any forward-looking statements and projections made by third parties included in this press release are not adopted by the Group and the Company is not responsible for such third-party statements and projections.
Media ContactBrand: China Medical System Holdings Ltd.Contact: CMS Investor RelationsEmail: ir@cms.net.cnWebsite: https://web.cms.net.cn/en/home/
Singapore - December 12, 2025 - (SeaPRwire) - In a clear signal of the city-state's booming alternative asset market, Whisky Mansion, a boutique storage facility housed in a heritage shophouse at Boat Quay, reported this week that its specialized vaults reached 90% capacity just four months after launch.
This rapid uptake highlights a shift in how local investors manage their "liquid portfolios." No longer content with remote industrial warehouses, Singapore’s collectors are increasingly demanding accessible, luxury storage within the Central Business District.
Solving the 'Invisible Asset' Problem Historically, alcohol storage in Singapore has been utilitarian. Malcolm De Silva, Managing Director of Rare & Refine Pte Ltd, argues this model creates a liquidity trap.
"The fundamental question every investor faces is: 'How does a collector sell his whisky when nobody sees it?'" said De Silva. "By turning our vault into a visible gallery, the collection remains 'alive' and showcase-ready."
To further solve this, Whisky Mansion has introduced a dedicated app allowing members to value, curate, and manage their collections digitally, ensuring assets are as visible on screen as they are in the vault.
A Community for the Rarest Whiskies The venue's appeal lies in its "Clubhouse" model. Whisky enthusiasts have flocked to the venue to view some of the rarest whiskies in the world and immerse themselves in a space where like-minded collectors gather.
The ecosystem features 'Curo,' a casual dining restaurant, and 'Curo Reserve,' a private members' club. Dedicated event rooms allow members to host masterclasses alongside their stored collections. "It turns storage into an experience," De Silva added. "It is a home for the community, not just a warehouse for bottles."
Future Expansion: Wine & Watches Demand for this luxury model is spilling over into other asset classes. Management reports a wave of inquiries from wine and watch enthusiasts seeking similar secure, climate-controlled environments.
With the current vault nearing capacity, Whisky Mansion confirmed plans to expand its boutique footprint to accommodate the growing waitlist.
Visit for more information
www.whiskymansion.com
For Press contacts, contact Dani – enquiries@whiskymansion.com
Dec. 11, 2025 - (SeaPRwire) - According to a report published by "The Icons", highly accomplished violist and Erhu Virtuoso Andy Lin successfully redefined the traditional image of leadership during his tenure as President of the World Taiwanese Chambers of Commerce – Junior Chapter (WTCCJC). By leveraging his unique blend of cultural artistry and human warmth, Lin injected a dynamic new spirit and connectivity into the international organization, and has now announced his next major endeavor: establishing a pioneering international academy of performing arts in Asia.
Unlike previous WTCCJC presidents, who often came from established corporate backgrounds, Lin, a musician with a Doctor of Musical Arts degree, chose a distinctly different path. He emphasized that his approach was not dictated by titles or authority, but by treating every member with "artistic sensitivity and human warmth." Lin described his leadership style as akin to performing "chamber music," promoting coordination and collective decision-making over command and control, stating that true harmony arises from finding balance among diverse voices rather than relying on the loudest voice.
Throughout his presidency, Lin traveled tirelessly across six continents, attending over thirty conferences and community events. Through impromptu musical performances and genuine one-on-one dialogue, he transformed WTCCJC into a comprehensive platform for cross-cultural exchange. Lin noted that this dedication to human connection and cultural engagement yielded the most fulfilling results, effectively turning a traditionally rule-bound organization into a bridge for shared vision and trust across continents.
A significant outcome of his tenure was the creation and performance of "The Song of WTCCJC." This original composition quickly became a powerful, unifying symbol for the organization, with its opening line, "When stars gather from every corner of the world," serving as an emotional anchor for global members. Lin stressed that culture is a form of governance that unites people through shared emotions and symbols, making cross-continental collaboration effortless and leading to tangible results, such as connecting premium Vietnamese coffee to the New York market and supporting a Japanese medical-aesthetics brand's entry into the U.S. healthcare system.
Following his successful term, Lin has shifted his focus to a new, major cultural initiative: establishing a world-class performing arts academy in Taiwan. This institution is planned to transcend conventional boundaries, integrating music, theatre, dance, interdisciplinary creation, and cultural technology. Lin's vision is to nurture creativity and cultural dialogue, making the academy a destination for global artists and effectively positioning Asia as a future center for the performing arts. He firmly believes that the school will become a meeting point for young artists from every nation, who will become "carriers of culture, taking Taiwan's stories back to the world—and bringing the world's colors into Taiwan." This culture-driven leadership model is set to continue its profound influence on the next generation of global leaders.
SHENZHEN, Dec 11, 2025 – (ACN Newswire) – China Medical System Holdings Limited (the “Group” or “CMS”) is pleased to announce that on 11 December 2025, the New Drug Application (NDA) of Class 1 Innovative Drug Y-3 for Injection (proposed English generic name: Loberamisal for Injection) (“Y-3 for Injection” or the “Product”) has been accepted by National Medical Products Administration of the People’s Republic of China (NMPA). The Product is a brain cytoprotectant indicated for the treatment of acute ischemic stroke.
With well-defined targets and clear mechanism of action, Y-3 for Injection is able to exert multiple therapeutic effects. As the world’s first brain cytoprotectant developed based on the important targets PSD95-nNOS and MPO, in the pathological processes of stroke, Y-3 for Injection acts on multiple key pathological processes of the ischemic cascade in ischemic stroke. Through multi-target, highly selective synergy, it is more conducive to exerting brain cytoprotective effects. The Product has an excellent therapeutic effect on ischemic stroke and the potential to prevent post-stroke depression and anxiety symptoms.
Y-3 for Injection demonstrates excellent clinical data with excellent efficacy and a favorable safety profile. The results of Phase II clinical trial of the Product in China indicated that among patients with ischemic stroke within 48 hours of onset, patients in the Y-3 group (40mg, qd) demonstrated a significantly higher proportion of patients achieving an excellent functional outcome (mRS of 0-1) at 90 days than those in the placebo group, with a rate difference of 16%. The Phase III clinical trial of the Product in China was conducted by Beijing Tiantan Hospital, Capital Medical University as the leading site. It has enrolled nearly 1,000 patients with acute ischemic stroke within 48 hours of onset across approximately 40 research centers nationwide, aiming to evaluate the efficacy and safety of Y-3 for Injection in treating patients with acute ischemic stroke within 48 hours of onset. The Phase III clinical study met the primary efficacy endpoint, with patients achieving significant clinical benefits and an overall favorable safety profile. The key study results are planned to be presented at international academic conferences, and the full study will be published in international academic journals.
The Central Nervous System (CNS) is one of the core advantageous fields of CMS, where a deeply integrated layout has been progressively established. The product portfolio has solidified the market foundation, including the marketed innovative drug VALTOCO (Diazepam Nasal Spray), the original brand drug Deanxit (Flupentixol and Melitracen Tablets), and the improved new drug ZUNVEYL (Benzgalantamine Gluconate Enteric-coated Tablets), which is currently under NDA review. The addition of Y-3 for Injection will further strengthen the product portfolio, generating highly efficient synergies in terms of expert networks and market resources. It is expected that if approved for marketing, Y-3 for Injection will bring a new generation of brain cytoprotectant with excellent efficacy and more comprehensive therapeutic effects to Chinese patients with ischemic stroke. Leveraging the successful commercialization experience and compliant and efficient operation system, the Group will accelerate the accessibility of innovative therapies to benefit more patients.
More Information about Y-3 for Injection
The pathological processes of acute ischemic stroke are highly complex and interconnected. There is an urgent clinical need for multi-target, multi-mechanism coordinated interventions to achieve more effective regulation of the complex ischemic cascade, thereby improving treatment outcomes and enhancing patients’ quality of life. Y-3 for Injection is able to uncouple PSD95-nNOS, inhibit MPO activity, and enhance the activity of α2-GABAA receptor (a subtype of GABAA receptor with antidepressant and anxiolytic effects). With this multi-target, highly selective synergistic mechanism, it is expected to achieve a technological breakthrough in the simultaneous intervention of “stroke treatment and prevention of post-stroke depression and anxiety”, making Y-3 for Injection a promising novel brain cytoprotectant with excellent efficacy and more comprehensive therapeutic effects.
The results of Phase II clinical trial of Y-3 for Injection for the treatment of acute ischemic stroke were presented as an oral poster at the 10th European Stroke Organisation Conference in 2024 (ESOC 2024). It indicated that among patients with ischemic stroke within 48 hours of onset, patients in the Y-3 group (20mg, 40mg, 60mg, qd) demonstrated a significantly higher proportion of patients achieving an excellent functional outcome (mRS of 0-1) at 90 days than those in the placebo group (20mg: 67.8% vs 60.7%, 40mg: 76.7% vs 60.7%, 60mg: 70.0% vs 60.7%). Moreover, the Product showed comparable safety to placebo in acute ischemic stroke patients, exhibiting good tolerability.
On 24 August 2023, the Group through its wholly-owned subsidiary entered into a Collaboration Agreement (the “Agreement”) with Neurodawn Pharmaceutical Co., Ltd. (“NeuroDawn”), a clinical needs-oriented pharmaceutical company driven by innovation and R&D. In accordance with the Agreement, the Group obtains an exclusive promotion right in mainland China, the Hong Kong Special Administrative Region, and the Macau Special Administrative Region. The term of the Agreement is permanent.
About Stroke
According to the Guideline for Prevention and Treatment of Cerebrovascular Disease (2024 Edition) issued by the National Health Commission, approximately 3.94 million new stroke cases occur in China each year, accounting for one-third of the global new cases[1]. Among these, ischemic stroke accounts for about 72%, with over 2.8 million new cases annually; the number of existing stroke patients in China has exceeded 28 million[1]. Data from China’s cause-of-death monitoring in 2021 shows that stroke-related deaths accounted for 23% of the national total deaths[1]. Over the past three decades, the disease burden of stroke-related disabilities in China has continued to increase[1]. Coupled with factors such as the accelerating aging of the population, the pressure of stroke prevention and control will further intensify in the future, posing enormous challenges to patients’ families and society[1]. In addition, post-stroke depression and anxiety are common complications of stroke, with incidence rates of approximately 30% and 25% respectively[2]. They can hinder the recovery of patients’ neurological functions, even increase the risk of death, and severely affect patients’ prognosis. Y-3 for Injection holds significant potential value for the long-term neurological function improvement and overall prognosis of a vast number of stroke patients, indicating broad market prospects.
About CMS
CMS is a platform company linking pharmaceutical innovation and commercialization with strong product lifecycle management capability, dedicated to providing competitive products and services to meet unmet medical needs.
CMS focuses on the global first-in-class (FIC) and best-in-class (BIC) innovative products, and efficiently promotes the clinical research, development and commercialization of innovative products, enabling the continuous transformation of scientific research into clinical practices to benefit patients.
CMS deeply engages in several specialty therapeutic fields, and has developed proven commercialization capabilities, extensive networks and expert resources, resulting in leading academic and market positions for its major marketed products. CMS continues to promote the in-depth development in its advantageous specialty fields, strengthening the competitiveness of the cardio-cerebrovascular/ gastroenterology/ ophthalmology/ skin health businesses, bringing economies of scale in specialty fields. Among them, the skin health business (Dermavon) has become a leading enterprise in its field, and is proposed to be listed independently on the SEHK. Meanwhile, CMS continuously promotes the operation and development of its integrated R&D, manufacturing and commercialization chain in Southeast Asia and the Middle East, capturing growth opportunities in emerging markets to support the high-quality and sustainable development of the Group.
Reference
1. National Health Commission of the People’s Republic of China. Guideline for Prevention and Treatment of Cerebrovascular Disease (2024 Edition) [J]. Chinese Journal of Magnetic Resonance Imaging, 2025, 16(1): 1-8. DOI: 10.12015/issn.1674-8034.2025.01.001.
2. Chen Xinyu, Lyu Xiaohan, Li Ruina, et al. Post-Stroke Anxiety [J]. International Journal of Cerebrovascular Disease, 2022, 30(2): 129-133. DOI: 10.3760/cma.j.issn.1673-4165.2022.02.010.
CMS Disclaimer and Forward-Looking Statements
This press release is not intended to promote any products to you and is not for advertising purposes. This press release does not recommend any drugs, medical devices and/or indications. If you want to know more about the diagnosis and treatment of specific diseases, please follow the opinions or guidance of your doctor or other medical and health professionals. Any treatment-related decisions made by healthcare professionals should be based on the patient’s specific circumstances and in accordance with the drug package insert.
This press release which has been prepared by CMS does not constitute any offer or invitation to purchase or subscribe for any securities, and shall not form the basis for or be relied on in connection with any contract or binding commitment whatsoever. This press release has been prepared by CMS based on information and data which it considers reliable, but CMS makes no representation or warranty, express or implied, whatsoever, and no reliance shall be placed on, the truth, accuracy, completeness, fairness and reasonableness of the contents of this press release. Certain matters discussed in this press release may contain statements regarding the Group’s market opportunity and business prospects that are individually and collectively forward-looking statements. Such forward-looking statements are not guarantees of future performance and are subject to known and unknown risks, uncertainties and assumptions that are difficult to predict. Any forward-looking statements and projections made by third parties included in this press release are not adopted by the Group and the Company is not responsible for such third-party statements and projections.
Media ContactBrand: China Medical System Holdings Ltd.Contact: CMS Investor RelationsEmail: ir@cms.net.cnWebsite: https://web.cms.net.cn/en/home/
New York, NY – December 08, 2025 – (SeaPRwire) – CryptoFeeDiscount, a premier cryptocurrency data aggregation platform, today announced the official launch of its advanced Crypto Trading Fee Savings Calculator. Designed for quant institutions and high-volume traders, this new data-driven engine reveals hidden transaction costs and identifies optimized execution strategies to reduce trading fees by up to 30%.
As crypto market volatility increases in late 2025, transaction costs have become a silent profit killer for active traders. A typical futures trader generating $5 to $10 million in monthly volume can lose upwards of $400 to $600 per month in unnecessary maker/taker fees without optimized account structuring.
CryptoFeeDiscount addresses this issue by providing a transparent, data-driven interface that allows users to:
Compare Real-Time Rates: Instantly visualize the cost difference between top-tier derivatives exchanges like Bitget and Binance.
Unlock VIP Fee Discounts for Free: Access exclusive, institutional-grade fee reductions usually reserved for VIP 1-3 levels, bypassing standard trading volume requirements.
Verify Promo Codes: Utilize the platform’s database of verified Referral Codes and Promo Codes to ensure maximum sign-up bonuses and lifetime fee rebates.
Discover Niche Opportunities: Filter exchanges by specific criteria, such as “Privacy-First” features for secure trading or high-leverage trading options.
“Most retail traders obsess over entry and exit prices but completely ignore the frictional cost of trading,” said James Anderson, Lead Analyst at CryptoFeeDiscount. “Our data shows that by simply switching execution venues or applying a verified discount code on platforms like Bitget, a scalper can increase their net profitability by over 15% annually. We built this calculator to make that math visible and actionable.”
The platform has already verified and indexed active promo codes for major platforms, ensuring users have access to the lowest possible rates currently available on the market, with savings reaching up to 30% on select crypto exchanges.
ABOUT CRYPTOFEEDISCOUNT
CryptoFeeDiscount is a leading financial technology website dedicated to transparency in cryptocurrency trading costs. Through its proprietary comparison engine and rigorous verification process, the platform helps traders find the best execution venues, referral codes, and sign-up bonuses.
MEDIA CONTACT
Brand: CryptoFeeDiscount
Contact: James Anderson
Email: team@CryptoFeeDiscount.com
Website: https://CryptoFeeDiscount.com
SUMMIT, N.J. – December 05, 2025 – (SeaPRwire) – Leapfrog Acquisition Corporation (the “Company”) announced today the pricing of its initial public offering of 12,500,000 units at a price of $10.00 per unit. The units are expected to commence trading on December 5, 2025 on the Global Market tier of The Nasdaq Stock Market LLC under the symbol LFACU.
The Company, which is led by Matthew R. Pollard, Abhay N. Pande and Kevin M. Murphy, is a special purpose acquisition company formed for the purpose of effecting a merger, amalgamation, share exchange, asset acquisition, share purchase, reorganization or similar business combination with one or more businesses.
Each unit sold in the offering consists of one Class A ordinary share (an “ordinary share”) and one half of one redeemable warrant with a strike price of $11.50 per ordinary share exercisable within 5 years of the Company completing an initial business combination. Once the securities comprising the units begin separate trading, the ordinary shares and warrants are expected to be listed on the Global Market tier of The Nasdaq Stock Market LLC under the symbols “LFAC” and “LFACW,” respectively.
BTIG, LLC is serving as the sole book-running manager of the offering. The underwriters have been granted a 45-day option to purchase up to an additional 1,875,000 units at the initial public offering price to cover over-allotments, if any.
A registration statement relating to these securities was declared effective by the Securities and Exchange Commission (the “SEC”) on December 4, 2025. The offering was made only by means of a prospectus, copies of which, when available, may be obtained by contacting BTIG, LLC, 65 East 55 Street, New York, NY 10022, by emailing ProspectusDelivery@btig.com, or by visiting the SEC’s website at www.sec.gov.
This press release shall not constitute an offer to sell or a solicitation of an offer to buy, nor shall there be any sale of these securities in any state or jurisdiction in which such offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of any such state or jurisdiction.
About Leapfrog Acquisition Corp
Leapfrog Acquisition Corp is a blank check company organized for the purpose of effecting a merger, amalgamation, share exchange, asset acquisition, share purchase, reorganization or engaging in any other similar business combination with one or more businesses or entities.
The Company is led by Chief Executive Officer, Matthew R. Pollard, President and Chief Investment Officer, Abhay N. Pande and Chief Financial Officer, Kevin M. Murphy.
The Company will prioritize businesses in the international energy supply chain and critical minerals sectors, including their related infrastructure in its search for attractive merger candidates.
Forward-Looking Statements
This press release includes forward-looking statements that involve risks and uncertainties. Forward-looking statements are statements that are not historical facts. Such forward-looking statements, including with respect to the anticipated use of the proceeds of the Company’s initial public offering, are subject to risks and uncertainties, which could cause actual results to differ from the forward-looking statements, including those set forth in the risk factors section of the registration statement and prospectus for the Company’s initial public offering. Copies of these documents can be accessed through the SEC’s website at www.sec.gov. No assurance can be given that the offering discussed above will be completed on the terms described, or at all, or that the net proceeds of the offering will be used as indicated. The Company expressly disclaims any obligations or undertaking to release publicly any updates or revisions to any forward-looking statements contained herein to reflect any change in the Company’s expectations with respect thereto or any change in events, conditions or circumstances on which any statement is based, except as required by law.
Media Contact
Company: Leapfrog Acquisition Corp
Contact: Media Team
Telephone: +1-201-379-4200
LinkedIn: https://www.linkedin.com/company/leapfrog-acquisition-corporation
Email In the US:
abhay@leapfrogspac.com
Email In Asia:
matt@leapfrogspac.com
kevin@leapfrogspac.com
Hong Kong – December 01, 2025 – (SeaPRwire) – ORCA, a global leader in on-site food-waste digestion technology, has partnered with Polytek Engineering Co. Ltd. as its exclusive distributor and service partner for Hong Kong. This collaboration marks an important step in ORCA’s continued expansion in Hong Kong and contributes to its wider presence throughout the Greater Bay Area and Southeast Asia markets.
Addressing Hong Kong’s Food Waste Challenge
Hong Kong continues to face significant challenges in waste management. In 2023, the city disposed of an average of 10,884 tonnes of municipal solids waste (MSW) per day. Food waste remained the largest single component, accounting for 29% or about 3,191 tonnes daily (info.gov.hk).
The government has made commendable progress—household food waste disposal fell by 12.6%, and recovery rates increased to 33% in 2023, up from 32% the previous year (info.gov.hk).
Still, the commercial and industrial sector contributes close to 1,000 tonnes of food waste daily, underscoring the need for scalable, sustainable solutions that can complement existing initiatives and support Hong Kong’s long-term waste reduction goals (epd.gov.hk).
A Partnership for Sustainable Impact
ORCA Digesters provide on-site solutions that convert food waste into environmentally safe water, reducing transportation emissions, protecting landfill capacity, and helping businesses meet sustainability targets.
Polytek Engineering is a trusted leader in professional kitchen, laundry, and cold storage systems, with decades of expertise in design, supply, installation, and after-sales service. Their role at the design and conception phase of projects uniquely positions them to integrate ORCA technology into new builds and retrofits, ensuring food waste diversion is considered from the outset.
About ORCA
ORCA is a pioneer in on-site food waste digestion technology, offering systems that help businesses reduce landfill and transportation reliance, cut greenhouse gas emissions and ultimately reduce food waste at the source.
“This partnership marks an important step toward addressing Hong Kong’s pressing food-waste challenge,” said Louis Anagnostakos — CEO, ORCA. “While ORCA continues to operate as an independent global company, by integrating our innovative technology with Polytek’s engineering expertise we can accelerate adoption of sustainable solutions across the commercial sector and the wider Greater Bay Area.”
About Polytek Engineering Co. Ltd
Polytek Engineering Co. Ltd is a leading provider of professional kitchen, laundry, and cold storage solutions in Hong Kong, Macau, and Mainland China. With expertise across design, supply, installation, and long-term service, Polytek delivers high-performance solutions tailored to client needs.
“Polytek has always focused on delivering high-performance, future-ready kitchen and facility solutions,” said Joseph Tsang — General Manager, Polytek. “Through this exclusive partnership, we can now bring ORCA’s proven food waste technology into projects at the earliest design stage—helping our clients build sustainability directly into their operations from inception.”
Bishkek, Kyrgyz Republic – November 29, 2025 – (SeaPRwire) – Kyrgyzstan has officially launched USDKG, a gold-backed stablecoin pegged 1:1 to the U.S. dollar, with an initial issue of $50 million. The token is issued on Tron and fully audited by ConsenSys Diligence, with future expansion slated to include Ethereum support.
The issuer, OJSC Virtual Asset Issuer, is a state-owned entity under the Ministry of Finance, operating within the legal framework established by the 2022 Law on Virtual Assets of the Kyrgyz Republic. The initiative represents a first-of-its-kind model in Central Asia, merging sovereign oversight with blockchain transparency.
The launch ceremony was attended by Sadyr Japarov, President of the Kyrgyz Republic, Almaz Baketaev, Minister of Finance, and Biibolot Mamytov, CEO of Gold Dollar, the project’s operator. During the event, the dignitaries pressed a symbolic “Launch Issuance” button, officially initiating the circulation of USDKG tokens.
The issuance of USDKG is carried out by a company with 100% state participation, ensuring a high level of investor trust and institutional reliability. A total of 50,000,000 USDKG tokens have been issued, each fully backed by physical gold reserves. Operational control — including gold management — is delegated to a private company registered in the Kyrgyz Republic, under a contractual agreement with the USDKG issuer.
This separation of responsibilities ensures independent operational oversight and positions USDKG outside the classification of a Central Bank Digital Currency (CBDC). The company responsible for managing USDKG’s gold reserves, has outlined plans to expand the backing to $500 million in the next phase, with a long-term target of $2 billion.
The stablecoin is fully compliant with FATF KYC/AML standards, and redemptions require standard identity verification. It is designed to facilitate financial inclusion.
Kyrgyzstan is among the first nations in the region to establish a comprehensive digital-asset regulatory framework, setting a precedent for state-supervised virtual currencies. Government representatives emphasized that such initiatives aim to enhance economic transparency and trade efficiency, rather than serve any geopolitical agenda. Officials also noted that USDKG complements, rather than competes with, the national monetary system.
The project reframes traditional narratives around state-issued and commodity-backed digital assets. Its gold collateral serves as a verifiable, inflation-resistant foundation, aligning with a growing market preference for transparent, real-asset-backed stablecoins. By combining physical reserves with on-chain verification, USDKG introduces a model of measurable stability uncommon in the current stablecoin landscape. The state-backed structure provides a clear regulatory framework built on accountability and public oversight.
The Kyrgyz initiative underscores a broader trend toward responsible digital-asset innovation in emerging markets. The government’s focus on regulatory discipline, transparency, and tangible reserves signals a pragmatic approach to blockchain-based modernization.
With USDKG, Kyrgyzstan positions itself as a regional first-mover in regulated asset-backed digital currencies — both bridging traditional finance and blockchain infrastructure and maintaining full sovereign oversight.
Media contact
Brand: Kyrgyzstan
Contact: Media team
Email: business@usdkg.com
Website: https://www.usdkg.com
Rodney Village, Rodney Bay, Gros-Islet St Lucia – November 28, 2025 – (SeaPRwire) – Capital Revo has announced a renewed expansion of its trader education framework following a measurable rise in platform engagement throughout 2025.The company stated that the latest update adds structured modules and improved navigation tools across its educational section, marking a key milestone in its ongoing commitment to supporting traders at all experience levels. This development underscores Capital Revo’s strategic focus on delivering accessible, analyst-supported learning resources in response to rising demand for credible market education.
The growing relevance of trader education within modern financial markets continues to reshape how brokerage firms present learning resources, and Capital Revo is positioning its educational section as a structured environment tailored for different stages of experience. The company has recently observed a steady increase in user engagement throughout its educational library as traders seek reliable ways to understand market dynamics without marketing-driven distractions. This development has drawn attention from industry observers who note that the segment is expanding in both depth and accessibility.
Market analysts describe the educational section as an evolving work in progress. The structure shows an intention to serve newcomers while still offering material that experienced individuals might revisit when refining methodologies. As many Capital Revo reviews on the internet suggest, the platform’s consistency in expanding its educational framework is one of the elements most frequently mentioned. That said, analysts often remark that the distinguishing feature is not simply the quantity of resources available but the organization of those materials in a manner that avoids overwhelming users. On the other hand, the steady growth of content reflects broader industry expectations in which education has become a foundational service rather than a secondary feature.
Specialists in financial communication who have examined the Capital Revo approach have pointed out how the company is maintaining attention on core trading topics. Observers note that this includes explanations of asset categories, interactive learning formats, and informational segments intended to clarify terminology that often confuses new market participants. The tone that emerges from external commentary suggests that the educational material is aimed at enabling learners to form structured habits, something frequently highlighted in Capital Revo opinions published across online trading communities. These observations illustrate how the materials are perceived within the wider ecosystem of retail investors seeking clarity in an increasingly digital environment.
The most notable aspect identified by reviewers and third-party commentators relates to the gradual build-up of the educational flow. Many have commented that the material appears designed to guide individuals from basic principles toward more advanced approaches without forcing accelerated progress. Market consultants see this as a workable strategy that reflects how many analysts of their generation learned to interpret charts, economic calendars, and policy. A methodical pace may feel slow at times, but it avoids creating unrealistic expectations. This approach is attracting wider media interest at a time when discussions about responsible trading content have become increasingly common.
External analysts observing the growth of Capital Revo’s presence in educational discussions highlight the absence of sensationalist content. Instead, the available learning tools seem to focus on structural understanding. Independent assessments confirm that this aligns with current demand across the retail segment, which increasingly favors clarity over aggressive messaging. This reflects how new entrants are approaching markets in 2025 as they attempt to digest concepts of risk, execution practices, and the mechanics behind market movement. This trend is not limited to beginners; regular users also expect educational components to be present within their trading platforms, observers say.
Experienced individuals sometimes revisit explanatory modules to refresh or update their frameworks. This has contributed to a growing body of commentary describing how Capital Revo’s educational materials are accessed by a diverse user base. Furthermore, analysts point out that the clarity of organization caters to those who prefer to explore topics at their own pace. Feedback from aggregated Capital Revo reviews often indicates that the structured navigation contributes to a smoother learning progression.
From a media standpoint, the current expansion of educational sections across brokerage platforms reflects a global trend. Many firms are competing to develop credible content that can withstand scrutiny from analysts and educators alike. In this context, Capital Revo’s efforts are being monitored as part of a broader industry movement toward more transparent, modular, and methodical learning tools. Commentators have emphasized that this type of development strengthens the industry by establishing consistent expectations for traders entering the market.
As the educational sector within online trading continues to expand, industry analysts anticipate further growth in the number of platforms revising their learning materials. Capital Revo has indicated through its public communication channels that education will remain a central component of its service offering. Market observers believe that this emphasis on structured learning will likely influence similar initiatives within other firms, particularly those looking to align with best practices noted in Capital Revo opinions and analysis-driven commentary.
About Capital Revo
Capital Revo is a financial services provider offering online trading infrastructure, educational resources, and technology-driven tools designed to support individuals throughout their market experience. The company focuses on delivering structured information intended to help traders understand core financial concepts and navigate market environments with clarity.
Media Contact
Capital Revo Communications DepartmentEmail: admin@capitalrevo.comWebsite: https://capitalrevo.com/
London, United Kingdom – November 25, 2025 – (SeaPRwire) – VELADUR, the UK-based multi-asset broker, announces a major milestone in its technology and investment strategy division as Senior Investment Specialist Eduard Becker drives a new wave of AI-enhanced portfolio solutions. The company highlights this achievement as part of its broader initiative to elevate performance, transparency, and client experience across global markets.
About VELADUR
VELADUR is a UK-based global broker offering CFD and multi-asset trading to clients in over 60 countries. Known for its integrity, cutting-edge technology, and hands-on client support, the firm is redefining the online investment experience.
Its guiding principle, “Master The Winds,” captures VELADUR’s long-term focus on security, education, and innovation ensuring every client, from beginner to professional, has access to institutional-grade tools and personal guidance.
About Eduard Becker
Experience and Expertise
Eduard Becker brings more than 18 years of real-world experience in derivatives, AI-enhanced strategies, and macro-driven portfolio management. Having advised both institutional investors and high-net-worth individuals, he is celebrated for blending data science with market intuition.Since joining VELADUR in early 2023, Becker has led the firm’s advanced investment division, mentoring analysts and creating proprietary AI-based risk-management systems that elevate both performance and client confidence.
Performance and Results
Under Becker’s leadership, VELADUR’s premium clients have seen remarkable outcomes. Over the last three years, portfolios managed or advised by him achieved average annual growth exceeding 46%, and a 58% year-on-year increase in adjusted returns during 2024.
These gains reflect Becker’s disciplined methodology combining adaptive algorithms, behavioural finance insights, and rigorous market research. His clients also benefit from reduced portfolio volatility, faster execution speeds, and precision-based risk controls built directly into VELADUR’s trading infrastructure.
Innovation and Technology
Becker spearheaded VELADUR’s push toward AI-powered trading ecosystems. The platform now integrates:
predictive machine-learning models for trade optimization,
live market-signal generation and automated alerts,
intelligent Take-Profit / Stop-Loss parameters, and
smart, data-driven charting interfaces for real-time decision-making.
These innovations allow clients to act swiftly and strategically in dynamic markets. Becker’s approach ensures that technology serves as an extension of the investor’s strategy — empowering traders, not replacing them.
“The right data architecture doesn’t just inform trading — it anticipates opportunity,” Becker noted. “When technology and human judgment align, performance follows naturally.”
Why Eduard’s Approach Matters
In an era of volatility and digital transformation, Becker’s methods embody the future of responsible investing. His frameworks help clients protect capital, identify high-probability entries, and leverage AI insights without excessive risk exposure.
By merging automation with personal mentorship, he ensures that even complex quantitative models remain accessible and actionable for clients. The result is a unique blend of innovation, discipline, and trust giving investors the confidence to thrive in unpredictable markets.
Becker’s educational commitment further distinguishes him: he conducts live workshops, 1-on-1 Zoom sessions, and elite “AI Strategy Labs” for premium clients, ensuring knowledge transfer alongside profit generation.
Client Impact and Recognition
VELADUR’s premium division now reports a client retention rate above 92%, reflecting both the measurable returns and the confidence Becker inspires. His leadership earned him the VELADUR Global Trading Excellence Award 2025, celebrating his exceptional results and contributions to financial innovation.His published works — including “High-Performance Trading for Large-Scale Investors” and “AI-Driven Approaches to CFD Trading for High-Net-Worth Clients” — have appeared in respected outlets, cementing his status as a thought leader in quantitative trading and risk-adaptive portfolio design.
Why Clients Choose VELADUR and Eduard Becker
Clients working with Eduard Becker enjoy the combined advantages of institutional-grade analytics and personal expertise. They gain:
Direct access to live strategy updates and AI-driven dashboards
Personalised portfolio reviews and private mentoring sessions
Tailored risk-management systems and performance reports
Global market access through a fully regulated, secure infrastructure
Becker’s leadership exemplifies VELADUR’s mission: to make sophisticated investment technology accessible, ethical, and profitable for every investor.
In Brief – Eduard Becker at a Glance
18+ years of experience in derivatives, algorithmic trading & portfolio management
Average annual portfolio growth of approx. 46–50% under his supervision
92%+ client retention rate within VELADUR’s premium segment
Lead architect of AI-powered trading tools: live signals, dynamic TP/SL, intuitive analytics
Recipient of VELADUR Global Trading Excellence Award 2025
Recognised thought-leader in AI-driven investing and CFD strategy
Eduard Becker’s pioneering work at VELADUR demonstrates that technology and human expertise can coexist to deliver superior results. His commitment to transparency, innovation, and investor education continues to elevate VELADUR as one of the most trusted and forward-thinking brokers in the UK and beyond.For discerning traders and investors seeking intelligent strategies backed by proven performance and personal guidance, VELADUR — guided by Eduard Becker — represents the future of smart, secure, AI-empowered investing.
Social Link
YouTube: https://www.youtube.com/@VELADUR
Media contact
Brand: VELADUR
Contact: Media team
Email: support@veladur.com
Website: https://www.veladur.com/
The Second International Commercial Arbitration Forum on the New Western Land-Sea Corridor Held in Chongqing, China
As economic and trade exchanges between China and ASEAN grow, the demand for international commercial dispute resolution is increasing. On November 21, the Second International Commercial Arbitration Forum on the New Western Land-Sea Corridor, themed “Sharing Opportunities, Promoting Development, and Building a New Hub for International Commercial Arbitration Services”, was held in Chongqing, China. The forum attracted over 200 representatives from domestic and foreign arbitration institutions, judicial authorities, universities, law firms, and enterprises, focusing on topics such as cross-border arbitration cooperation, talent cultivation in foreign-related arbitration, and the alignment of international arbitration rules.
A highlight of the forum was the signing of cooperation agreements between the Chongqing Arbitration Commission (Chongqing Court of International Commercial Arbitration) and five foreign arbitration institutions from Singapore, Thailand, Malaysia, Hungary, and Lebanon. The parties will collaborate on talent cultivation and training mechanisms, mutual recommendation of arbitrators, and exchanges in arbitration practices. For enterprises at home and abroad, this means they can opt for the Chongqing Arbitration Commission (Chongqing Court of International Commercial Arbitration) or its partner institutions to resolve disputes in the future, and will benefit from a smoother cross-border dispute resolution coordination mechanism and more professional support in international arbitration practices.
During the forum, the Chongqing Arbitration Commission (Chongqing Court of International Commercial Arbitration) reached joint training agreements with eight universities and research institutions, including China University of Political Science and Law and Southwest University of Political Science and Law. These initiatives aim to cultivate interdisciplinary talents in foreign-related arbitration with a command of international arbitration rules and the ability to apply them, multilingual communication skills, and practical experience in cross-border arbitration. Additionally, a group of experts from the International Commercial Arbitration Expert Pool and international arbitrators have been appointed to expand the professional team and enhance talent supply, providing robust support for resolving cross-border commercial disputes.
The forum released Chongqing’s Achievements in Construction of the International Commercial Arbitration Center. As introduced, the Chongqing Arbitration Commission (Chongqing Court of International Commercial Arbitration) has appointed 178 foreign-related arbitrators and introduced multilingual arbitration rules and a digital service system. According to the official data, the foreign-related arbitration awards of the Chongqing Arbitration Commission (Chongqing Court of International Commercial Arbitration) have been recognized and enforced in over 20 countries and regions, with the total value of foreign-related arbitration cases exceeding RMB 25 billion. An international commercial arbitration cooperation system targeting ASEAN and extending to the countries and regions participating in the Belt and Road Initiative has taken initial shape.
The thematic discussion session of the forum garnered significant attention, and the attending experts engaged in in-depth exchanges on key issues such as the internationalization and prospects of Chinese arbitration, implementation of the newly revised Arbitration Law of the People’s Republic of China, development of the world-class arbitration institutions, and cross-border dispute resolution.
By strengthening cross-border arbitration cooperation and enhancing foreign-related service capabilities, Chongqing is committed to providing enterprises with dispute resolution options featuring “easy access”, “smooth communication” and “efficient enforcement” amid ongoing regional economic and trade development. Relevant officials stated that efforts will continue to advance the construction of an international commercial arbitration cooperation and service system targeting Southeast Asia and extending to the countries and regions participating in the Belt and Road Initiative, thus offering more specialized and internationalized dispute resolution support for cross-border economic and trade activities.
With the advancement of relevant cooperation mechanisms as well as talent and rule development, the Chongqing Arbitration Commission (Chongqing Court of International Commercial Arbitration) will provide Chinese and ASEAN enterprises with more diverse options and robust service guarantees for resolving cross-border disputes.
A significant recognition from Japan, one of the world’s most trusted and disciplined markets
Tokyo, Japan – November 22, 2025 – (SeaPRwire) – playX has been presented with the prestigious “Enterprise Award” at the Asia Golden Star Awards in Tokyo. CEO Mark Carter attended the ceremony in person to accept the award on behalf of the playX team.
This recognition is especially meaningful because it comes from Japan—a country globally respected for its strict standards, disciplined evaluation methods, and strong culture of fairness. Being acknowledged in such an environment represents a powerful affirmation of playX’s credibility and operational integrity.
Event highlights video: https://youtu.be/SkOmoMbcLVA?si=l7-eD2d0xvvJvodK
“Being acknowledged in Japan truly means something,” said Carter. “Japan is known for its precision, discipline, and commitment to trust. When a market this rigorous recognizes your enterprise, it gives users across Asia and around the world a deeper sense of confidence.”
Why playX Was Selected:
– AI-driven integrity systems ensuring fairness
– Transparent user experience
– Strong international development
– Long-term commitment to user trust
This award marks a significant milestone as playX expands across Asia, further strengthening its position as a trusted, forward‑looking gaming technology enterprise.
Official Channels
Facebook: https://www.facebook.com/playX.my
Instagram: https://www.instagram.com/playx.my/
Telegram: https://t.me/playXofficial
YouTube: https://www.youtube.com/@playXOfficial8
Media contact
Brand: playX
Contact: Media team
Email: marking@playxgaming.com
Website: https://playx.my
New York, NY – November 22, 2025 – (SeaPRwire) – Innovative Warehouse Solutions (IWS), a leading New York-based eCommerce fulfillment company, has officially signed a partnership deal with Amazon Shipping, Amazon’s small parcel delivery network.
Historically focused solely on supporting Amazon’s own eCommerce operations, Amazon Shipping now reaches 90% of the U.S. population with transit speeds that compete with UPS Ground and USPS Ground Advantage. In 2024 alone, the service delivered 5.7 billion packages, securing its position as the largest small parcel carrier in the U.S. by volume.
Addressing questions about the unusual nature of a fulfillment company partnering with its biggest competitor, Brian Gibbons, CEO of IWS, emphasized that Amazon is a net positive for the entire eCommerce ecosystem. Now in his early 40s, Gibbons recalled a time when online shopping felt risky, noting that Amazon transformed the industry by introducing safety, trust, and standards. This foundation enabled a generation of entrepreneurs to launch businesses—from Shopify stores to multi-channel operations—with Gibbons adding, “We’re all kind of standing on Amazon’s shoulders.”
Gibbons confirmed that most brands supported by IWS also sell on Amazon, framing the platform as a core channel akin to Sears or Macy’s in the 1990s, but not the sole revenue stream. “Smart brands diversify,” he explained, noting that IWS clients typically sell across Shopify, Amazon, Faire, Bloomingdale’s, and other platforms. IWS’s strength lies in its omni-channel fulfillment solution, which aggregates orders from all channels, leverages a centralized inventory pool, and tailors fulfillment to each channel’s unique requirements—resulting in lower holding costs and greater efficiency for brands.
When asked what IWS offers that Amazon cannot, Gibbons acknowledged Amazon’s exceptional operational efficiency but highlighted customization as a key differentiator. Services like retail EDI, kitting, and channel-specific packaging are areas where third-party fulfillment providers like IWS deliver more value, as Amazon likely does not see sufficient ROI to prioritize these tailored offerings.
Gibbons cited multiple factors driving the partnership with Amazon Shipping, starting with the stagnation of the small parcel 3PL industry over the past 20 years. While USPS’s Ground Advantage represented progress, legacy carriers continue to impose outdated surcharges—including residential delivery fees and fuel surcharges—even as residential deliveries have become standard. Amazon Shipping is disrupting this model by eliminating residential surcharges and offering deep discounts on fuel charges unless prices spike significantly, a change that Gibbons described as “huge for eCommerce brands.”
Beyond cost, performance was a critical consideration. Gibbons noted that smaller carriers may offer attractive rates but often lack reach and speed, whereas Amazon Shipping provides 7-day-a-week delivery, faster windows for long-distance shipments, and employs uniformed drivers in branded trucks instead of gig workers. Additionally, the service includes delivery photo confirmation— a feature rarely offered at scale by other carriers.
The partnership aligns with IWS’s mission to operate as an extension of its clients’ businesses: while clients manage product, marketing, and conversion, IWS handles logistics. This requires staying ahead of industry trends and identifying opportunities to enhance cost-effectiveness, speed, and reliability—all areas where Amazon Shipping excels. “In many cases, we’re giving our brands faster delivery at a lower cost,” Gibbons said. “That’s a no-brainer.”
With this new partnership, IWS continues its commitment to providing flexible, tech-forward fulfillment solutions that empower growing eCommerce brands to thrive in an increasingly competitive market.
Media contact
Brand: Innovative Warehouse Solutions
Contact: Media team
Email: Info@invwhs.com
Website: https://invwhs.com
